Ayurvedic, Siddha, Unani and Homoeopathic drugs are regulated in accordance with the exclusive provisions for them in the Drugs & Cosmetics Act, 1940 and Rules thereunder. These drugs have to adhere to such standards and quality control parameters as given in the authoritative books, pharmacopoeias and formularies of Ayurvedic, Siddha, Unani and Homoeopathic systems, which are different from that prescribed for allopathic medicines. Till date, monographs of quality standards of 600 single drugs & 152 compound formulations of Ayurveda, 298 single drugs & 100 compound formulations of Unani system, 139 single drugs of Siddha and 1016 Homoeopathic drugs have been published in the respective pharmacopoeias.
States have reported incidents of substandard medicine samples and action taken against them. 11889 samples of AYUSH medicines were tested in 24 states during the last three years from 2013-14 to 2015-16, out of which 254 samples failed in quality testing. State Licensing Authorities initiated appropriate action against the samples not complying with the standards and issued show cause notices or suspended/cancelled licenses, recalled the relevant batch of finished goods from the market and initiated prosecution.
Exclusive regulatory provisions for standards and quality of Ayurvedic, Siddha, Unani and Homoeopathic medicines exist in the Drugs & Cosmetics Act, 1940 and Rules thereunder. Drugs and Cosmetics Rules, 1945 are amended in consultation with the respective Drugs Technical Advisory Board for imposing effective quality control. As of now there is no proposal in the Ministry of AYUSH to introduce new legislation for grading and standardization of AYUSH products.
Powered by Capital Market - Live News
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
